Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tetanus-diphtheria-acellular Pertussis (Tdap)”

59 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 59 results

Post-approval studies (Phase 4)Study completedNCT00610168
What this trial is testing

Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination.

Who this might be right for
Acellular PertussisTetanusDiphtheria
GlaxoSmithKline 82
Large-scale testing (Phase 3)Study completedNCT01738477
What this trial is testing

Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Previously Boosted Young Adults

Who this might be right for
TetanusAcellular PertussisDiphtheria
GlaxoSmithKline 165
Large-scale testing (Phase 3)Study completedNCT02477995
What this trial is testing

Study of Adsorption Tetanus-diphtheria-acellular Pertussis (DTaP) Vaccine in Healthy 3 to 5 Months Infants

Who this might be right for
Pertussis
Jiangsu Province Centers for Disease Control and Prevention 1,200
Not applicableStudy completedNCT07444502
What this trial is testing

Safety Monitoring of Boostagen® Vaccine in Thailand

Who this might be right for
Pertussis (Whooping Cough)TetanusDiphtheria
BioNet-Asia Co., Ltd. 10,727
Large-scale testing (Phase 3)Study completedNCT00109330
What this trial is testing

A Combined Tdap Vaccine Used As A Booster Compared To Licensed Td Vaccine

Who this might be right for
DiphtheriaTetanusAcellular Pertussis
GlaxoSmithKline 4,116
Post-approval studies (Phase 4)Study completedNCT00457249
What this trial is testing

A Trial to Evaluate the Safety and Immunogenicity of ADACEL® Vaccine in Persons 65 Years of Age and Older

Who this might be right for
PertussisTetanusDiphtheria
Sanofi 1,564
Early research (Phase 1)Looking for participantsNCT07203755
What this trial is testing

Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine

Who this might be right for
Diphtheria, Tetanus and Acellular PertussisEpidemic MeningitisHaemophilus Influenzae Type B Infection
CanSino Biologics Inc. 260
Testing effectiveness (Phase 2)Looking for participantsNCT06997627
What this trial is testing

A Phase I/II Study to Evaluate the Safety and Immunogenicity of GC3111B in Healthy Adults

Who this might be right for
Tetanus-diphtheria-acellular Pertussis (Tdap)
GC Biopharma Corp 120
Large-scale testing (Phase 3)Study completedNCT00655148
What this trial is testing

Safety and Immunogenicity of a New Serum-free DTaP-IPVvero Combination Vaccine

Who this might be right for
Active Immunization
Statens Serum Institut 817
Large-scale testing (Phase 3)Study completedNCT00489970
What this trial is testing

Persistence Study of GSK Biologicals' Tdap Vaccine 1, 3, 5 and 9 Years Following Administration as an Initial Single Dose in Healthy Young Adults and to Evaluate the Immunogenicity and Safety of Boostrix as a Second Dose of Tdap, When Administered at Year 9

Who this might be right for
Acellular PertussisTetanusDiphtheria
GlaxoSmithKline 1,954
Testing effectiveness (Phase 2)Study completedNCT04071158
What this trial is testing

A RSV VACCINE WHEN GIVEN TOGETHER WITH TDAP IN HEALTHY NONPREGNANT WOMEN AGED BETWEEN 18 TO 49 YEARS

Who this might be right for
Respiratory Tract Infection
Pfizer 713
Large-scale testing (Phase 3)Study completedNCT01200368
What this trial is testing

Trial Evaluating a 13-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants

Who this might be right for
Healthy Subjects
Pfizer 551
Post-approval studies (Phase 4)Looking for participantsNCT06135636
What this trial is testing

Assessing Interventions to Increase Tdap Acceptance for Non-birthing Partners in Pregnancy

Who this might be right for
Non-birthing Partner Vaccination in PregnancyTdap - Tetanus, Diphtheria and Acellular Pertussis VaccinationVaccine Exposure During Pregnancy
Women and Infants Hospital of Rhode Island 150
Large-scale testing (Phase 3)Study completedNCT02089347
What this trial is testing

Study of SP306 Given Intramuscularly Compared to DT Given Subcutaneously in Japanese Adolescents 11 - 12 Years Old

Who this might be right for
TetanusDiphtheriaPertussis
Sanofi Pasteur, a Sanofi Company 534
Not applicableStudy completedNCT03824093
What this trial is testing

High and Low Resource Interventions to Promote HPV Vaccines

Who this might be right for
Human Papilloma VirusTdap - Tetanus, Diphtheria and Acellular Pertussis VaccinationMeningitis, Meningococcal+2 more
Children's Mercy Hospital Kansas City 225
Very early researchStudy completedNCT03498300
What this trial is testing

Seroprevalence of Bordetella Pertussis Antibodies and Anti-pertussis Antibody Response After a Single Dose of Tdap in Pregnant Thai Women

Who this might be right for
PertussisPregnancy Related
Mahidol University 129
Early research (Phase 1)Study completedNCT02382913
What this trial is testing

Persistency Study After aP / Tdap Booster Vaccines in Adult Subjects (V113_01 Extension 1)

Who this might be right for
Pertussis
Novartis 315
Large-scale testing (Phase 3)Study completedNCT00553228
What this trial is testing

Pertussis Maternal Immunization Study

Who this might be right for
Pregnant Women
Scott Halperin 320
Post-approval studies (Phase 4)Study completedNCT01711645
What this trial is testing

Tdap Vaccine in Post-Partum Women

Who this might be right for
DiphtheriaPertussisTetanus
National Institute of Allergy and Infectious Diseases (NIAID) 55
Testing effectiveness (Phase 2)Study completedNCT00263692
What this trial is testing

Comparison of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP and IPV Separately Administered Vaccines in Terms of Immune Response and Safety

Who this might be right for
DiphtheriaAcellular PertussisTetanus
GlaxoSmithKline 401
Next Page